PTWO PONO CAPITAL TWO INC.

SBC Medical Announces Attendance at Upcoming Investor Events

SBC Medical Announces Attendance at Upcoming Investor Events

IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced its upcoming investor event attendance.

SBC Medical managements will be participating in a webcast company presentation and will also attend 1-x-1 investor meetings at these upcoming events:

1.    Lytham Partners Spring 2025 Virtual Investor Conference

Company Webcast

Thursday, May 29, 2025, at 2:00-2:30 PM(ET)

The webcast can be accessed at 

Post-Event Access: Same as above

1x1 Meetings

To arrange a meeting at 

2.    Noble Capital Markets’ Emerging Growth Virtual Equity Conference 

Company Webcast

Thursday, June 5, 2025

The webcast can be accessed at 

Post-Event Access: 

1x1 Meetings

To arrange a meeting at

3.    Sidoti Small-Cap Virtual Conference

Company Webcast

Wednesday, June 11, 2025, at 8:30-9:00 AM(ET)

The webcast and post-event access will be provided when available.

1x1 Meetings

To arrange a meeting at 

4.    Zacks SCR Life Sciences Virtual Investor Forum

Company Webcast

Thursday, June 12, 2025, at 10:30-11:00AM(ET)

The webcast and post-event access will be provided when available.

About SBC Medical

SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.

For more information, visit-holdings.com/

SBC Medical Group Holdings Incorporated

Hikaru Fukui / Head of Investor Relations

e-mail:



EN
28/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PONO CAPITAL TWO INC.

 PRESS RELEASE

SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing ...

SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group’s portfolio, including Shonan Beauty Clinic, one of Japan’s largest aesthetic medical br...

 PRESS RELEASE

SBC Medical Participated in 4 Investor Conferences in May and June 202...

SBC Medical Participated in 4 Investor Conferences in May and June 2025 IRVINE, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, recently participated in several prominent investor conferences throughout May and June 2025. SBC Medical delivered webcast presentations and conducted one-on-one meetings with institutional investors. Presentation videos can be viewed at the links below:Below is a summary of the Company's participation in recent investor conference...

 PRESS RELEASE

Participation in “The 113th Congress of Japan Society of Aesthetic Sur...

Participation in “The 113th Congress of Japan Society of Aesthetic Surgery,” May 2025 ~Record Participation for SBC Medical. 22 doctors Present Insights in Their Respective Fields~ IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”) today announced that a total of 22 representatives, including Yoshiyuki Aikawa, CEO of SBC Medical, and doctors from Shonan Beauty Clinic, a clinic operated under the management support of SBC Medical Group, a consolidated subsidiary, presented their research findings at “The 113th Congress ...

 PRESS RELEASE

SBC Medical Announces Attendance at Upcoming Investor Events

SBC Medical Announces Attendance at Upcoming Investor Events IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced its upcoming investor event attendance. SBC Medical managements will be participating in a webcast company presentation and will also attend 1-x-1 investor meetings at these upcoming events: 1.    Lytham Partners Spring 2025 Virtual Investor Conference Company WebcastThursday, May 29, 2025, at 2:00-2:30 PM(ET)...

 PRESS RELEASE

SBC Medical Group Holdings Announces Approval of Share Repurchase Prog...

SBC Medical Group Holdings Announces Approval of Share Repurchase Program and Commencement of Share Repurchases IRVINE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Nasdaq: SBC, “the Company”) today announces that its Board of Directors has approved the following share repurchase program and will commence repurchasing its own shares as early as May 20, 2025. Share Repurchase Program Maximum aggregate amount: US $5 millionImplementation period: May 20, 2025 – May 20, 2026Funding source: Surplus cash and future free cash flow The Company believes its c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch